How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

24/06/2022 1h 13min

                    How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market

Listen " How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market "

Episode Synopsis


In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific.

Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer.

This episode is sponsored by AcuityMD.

Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

More episodes of the podcast DeviceTalks Podcast Network